Patel MK, Gacic-Dobo M, Strebel PM, Dabbagh A, Mulders MN, Okwo-Bele JM, et al. Progress toward regional measles elimination-worldwide, 2000–2015. MMWR Morb Mortal Wkly Rep. 2016;65:1228–33.

Article  PubMed  Google Scholar 

Vynnycky E, Adams EJ, Cutts FT, Reef SE, Navar AM, Simons E, et al. Using seroprevalence and immunisation coverage data to estimate the global burden of congenital rubella syndrome, 1996–2010: a systematic review. PLoS One. 2016;11:e0149160.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization. Measles and rubella strategic framework 2021–2030. https://www.who.int/publications/i/item/measles-and-rubella-strategic-framework-2021-2030. Accessed 8 Nov 2020.

Dixon MG, Ferrari M, Antoni S, Li X, Portnoy A, Lambert B, et al. Progress toward regional measles elimination-worldwide, 2000–2020. MMWR Morb Mortal Wkly Rep. 2021;70:1563–9.

Article  PubMed  PubMed Central  Google Scholar 

Kuter BJ, Marshall GS, Fergie J, Schmidt E, Pawaskar M. Prevention of measles, mumps and rubella: 40 years of global experience with M-M-RII. Hum Vaccin Immunother. 2021;17:5372–83.

Article  CAS  PubMed  Google Scholar 

Su Q. Study on the supplementary immunization strategy for measles and rubella elimination in China. Beijing: Chinese Center for Disease Control and Prevention; 2019 (in Chinese).

Ma C, Hao L, Ma J, Zhang Y, Cao L, Liang X, et al. Measles epidemiological characteristics and progress of measles elimination in China, 2010. Chin J Vaccin Immun. 2011;17:242–8 (in Chinese).

Google Scholar 

Xu W, Zhang Y, Wang H, Zhu Z, Mao N, Mulders MN, et al. Global and national laboratory networks support high quality surveillance for measles and rubella. Int Health. 2017;9:184–9.

Article  PubMed  Google Scholar 

Lixia W, Guang Z, Lee LA, Zhiwei Y, Jingjin Y, Jun Z, et al. Progress in accelerated measles control in the People’s Republic of China, 1991–2000. J Infect Dis. 2003;187(Suppl 1):S252–7.

Article  PubMed  Google Scholar 

World Health Organization. Regional Office for the Western Pacific. Measles-rubella bulletin 2024. https://iris.who.int/handle/10665/375987. Accessed 14 Feb 2024.

Wang H, An Z, Yin Z. Achievements in prevention and control of seven infectious diseases targeted by the National Immunization Program in China across 70 years. Chin J Vaccin Immun. 2019;25:359–67 (in Chinese).

CAS  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10:89.

Article  PubMed  PubMed Central  Google Scholar 

Zhou Y, Gu Y, Hu Y, Xing W. The Joanna Briggs institute critical appraisal tools for use in systematic review: prevalence study and analytical cross sectional study. J Nurs Train. 2018;33:219–21 (in Chinese).

Google Scholar 

Li S, Wang J, Zhou J, Tang X, Ling H. Establishment of a mathematical model for the analysis of anti-measles antibody reduction trend in children aged 1–8 months. Shanghai J Prev Med. 2022;34:568–70 (in Chinese).

CAS  Google Scholar 

Winter AK, Martinez ME, Cutts FT, Moss WJ, Ferrari MJ, McKee A, et al. Benefits and challenges in using seroprevalence data to inform models for measles and rubella elimination. J Infect Dis. 2018;218:355–64.

Article  PubMed  PubMed Central  Google Scholar 

Moss WJ, Shendale S, Lindstrand A, O’Brien KL, Turner N, Goodman T, et al. Feasibility assessment of measles and rubella eradication. Vaccine. 2021;39:3544–59.

Article  PubMed  Google Scholar 

Durrheim DN, Orenstein WA, Schluter WW. Assessing population immunity for measles elimination-the promise and peril of serosurveys. Vaccine. 2018;36:4001–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui S, Wang W, Cong Y, Du H, Sun L, Xu X, et al. Epidemiological investigation of two measles cases caused by genotype B3 virus in Hebei, 2023. Dis Surveill. 2024;39:1227–30 (in Chinese).

Google Scholar 

Zhu Z, Cui A, Zhang Y, Mao N, Liu Y. Transmission dynamics of the rubella virus circulating in China during 2010–2019: 2 lineage switches between genotypes 1E and 2B. Clin Infect Dis. 2021;73:1157–64.

Article  PubMed  Google Scholar 

Liu Q, Tang L, Wen N, Yang H, Wang X, Ma C, et al. Epidemiology of measles in China, 2020. Chin J Vaccin Immun. 2022;28:135–9 (in Chinese).

Google Scholar 

Liu Y, Cui A, Guo J, Deng L, Fan L, Wei H, et al. Epidemiological and genetic characteristics of rubella virus in China, 2020. Chin J Virol. 2021;37:638–47 (in Chinese).

Google Scholar 

Ma C, Hao L, Wen N, Fan C, Yang H, Wang H, et al. Epidemiology of measles in China, 2019. Chin J Virol. 2020;26:493–7 (in Chinese).

Google Scholar 

Ma C, Su Q, Hao L, Wen N, Fan C, Yang H, et al. Epidemiology of measles in China, 2017–2018. Chin J Vaccin Immun. 2020;26:5–8 (in Chinese).

CAS  Google Scholar 

Su Q, Hao L, Ma C, Wen N, Fan C, Yang H, et al. Epidemiology of measles in China, 2015–2016. Chin J Vaccin Immun. 2018;24:146–51 (in Chinese).

Google Scholar 

Guerra FM, Crowcroft NS, Friedman L, Deeks SL, Halperin SA, Severini A, et al. Waning of measles maternal antibody in infants in measles elimination settings-a systematic literature review. Vaccine. 2018;36:1248–55.

Article  PubMed  Google Scholar 

Waaijenborg S, Hahne SJ, Mollema L, Smits GP, Berbers GA, van der Klis FR, et al. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013;208:10–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age. J Infect Dis. 2004;189(Suppl 1):S116–22.

PubMed  Google Scholar 

Notice on further strengthening immunization prevention work including planned immunization. Gazette of the National Health Commission of the People's Republic of China. Beijing: Ministry of Health; 2003 (in Chinese).

Su Q, Ma C, Wen N, Fan C, Yang H, Wang H, et al. Epidemiological profile and progress toward rubella elimination in China. 10 years after nationwide introduction of rubella vaccine. Vaccine. 2018;36:2079–85.

Article  PubMed  Google Scholar 

Hao L, Ma C, Wannemuehler KA, Su Q, An Z, Cairns L, et al. Risk factors for measles in children aged 8 months-14 years in China after nationwide measles campaign: a multi-site case-control study, 2012–2013. Vaccine. 2016;34:6545–52.

Article  PubMed  PubMed Central  Google Scholar 

Li Y, Ma C, Hao L, Wag F, Wen N, Yang H, et al. Epidemiology of rubella in China, 2018–2019. Chin J Vaccin Immun. 2021;27:62–6 (in Chinese).

Google Scholar 

Yang W, Wen L, Li SL, Chen K, Zhang WY, Shaman J. Geospatial characteristics of measles transmission in China during 2005–2014. PLoS Comput Biol. 2017;13:e1005474.

Article  PubMed  PubMed Central  Google Scholar 

Hao L, Glasser JW, Su Q, Ma C, Feng Z, Yin Z, et al. Evaluating vaccination policies to accelerate measles elimination in China: a meta-population modelling study. Int J Epidemiol. 2019;48:1240–51.

Article  PubMed  Google Scholar 

Wang Q, Wang W, Winter AK, Zhan Z, Ajelli M, Trentini F, et al. Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study. Nat Commun. 2023;14:1746.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Knapp JK, Mariano KM, Pastore R, Grabovac V, Takashima Y, Alexander JJ, et al. Progress toward rubella elimination-Western Pacific region, 2000–2019. MMWR Morb Mortal Wkly Rep. 2020;69:744–50.

Article  PubMed  PubMed Central  Google Scholar 

Wang M, Yuan Q, Deng PF, Fei Y, Zhang H, Zhou F, et al. Measles, mumps, and rubella revaccination in children after completion of chemotherapy and hematopoietic stem cell transplantation: a single-center prospective efficacy and safety analysis. World J Pediatr. 2023;19:1062–70.

Article  CAS  PubMed  Google Scholar